Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGD | P52209 | 3/20 | 0.58 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.47 |
| ▸ | PRKCA | P17252 | 2/20 | 0.45 |
| ▸ | PGK1 | P00558 | 1/20 | 0.42 |
| ▸ | PGK2 | P07205 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14513725 | 0.85 | PGD (0.58) | PGDPGK1PGK2ENPP2LPAR3 | |
| SCHEMBL26207056 | 0.85 | PGD (0.58) | PGDS1PR1PGK1PGK2ENPP2 | |
| SCHEMBL14513716 | 0.85 | PGD (0.58) | PGDPGK1PGK2ENPP2LPAR3 | |
| SCHEMBL4572660 | 0.83 | PGD (0.56) | PGDPGK1PGK2ENPP2LPAR3 | |
| SCHEMBL5959432 | 0.83 | PGD (0.56) | PGDPGK1PGK2ENPP2LPAR3 | |
| SCHEMBL20673 | 0.82 | S1PR1 (0.43) | PGDS1PR1PGK1PGK2ENPP2 | |
| SCHEMBL17898548 | 0.80 | PGD (0.54) | PGDPGK1PGK2ENPP2LPAR3 | |
| SCHEMBL11326756 | 0.80 | S1PR1 (0.44) | PGDS1PR1PRKCAPGK1PGK2 | |
| SCHEMBL16058993 | 0.79 | PGD (0.42) | PGDS1PR1PGK1PGK2ENPP2 | |
| SCHEMBL9613458 | 0.79 | PGD (0.40) | PGDS1PR1PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0340759-A1 | Salts of O-mono (di)-acetyl-glycero-mono-(bis)-(di)-phosphates of L-acetyl-carnitine and of L-acetyl carnitine esters | MAGIS FARMACEUTICI S.p.A. (IT) | 1989-11-08 | — | — | EP | claimed |
| EP-0335396-A1 | Glycero-phosphoric and -diphosphoric acids derivatives of L-carnitine or L-carnitine esters | MAGIS FARMACEUTICI S.p.A. (IT) | 1989-10-04 | — | — | EP | claimed |
| US-5780617-A | PHOSPHORYLATION OF A PHOSPHATIDES WITH A NUCLEOTIDES | NEXSTAR PHARMACEUTICALS, INC. (US) | 1998-07-14 | — | — | US | disclosed |
| EP-0531452-A4 | SYNTHESIS OF GLYCEROL DI- AND TRIPHOSPHATE DERIVATIVES | — | 1993-06-09 | — | — | EP | disclosed |
| EP-0531452-A1 | SYNTHESIS OF GLYCEROL DI- AND TRIPHOSPHATE DERIVATIVES | NeXstar Pharmaceuticals, Inc. (US) | 1993-03-17 | — | — | EP | disclosed |
| WO-1991018914-A1 | SYNTHESIS OF GLYCEROL DI- AND TRIPHOSPHATE DERIVATIVES | VICAL, INC. (US) | 1991-12-12 | — | — | WO | disclosed |